XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FAIR VALUE PRICING MODEL (Details)
Mar. 31, 2023
Integer
Jan. 09, 2023
Integer
Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability measurement input [1] 0.34 1.44
Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contractual term (years) [2] 5 years 3 months 18 days 5 years 6 months
Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability measurement input 3.5 3.6
Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability measurement input 100 100
Measurement Input, Expected Dividend Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability measurement input 0 0
[1] Based on the trading value of common stock of Vivos Therapeutics, Inc. as of January 9, 2023 and each presented period ending date.
[2] The valuation of warrants is based on the contractual term of the warrant rather than the expected term.